ATP-dependent Lon protease controls tumor bioenergetics by reprogramming mitochondrial activity

Area of Science:

• Mitochondrial biology
• Oncology
• Molecular genetics

Background:

• Mitochondrial quality control is essential for cellular health.
• The Lon protease (LONP1) is a key component of this machinery.
• Dysregulation of mitochondrial function is implicated in cancer development.

Purpose of the Study:

• To investigate the role of Lon protease (LONP1) in cellular viability and oncogenesis.
• To determine the impact of LONP1 deficiency and overexpression on tumor formation.
• To explore LONP1's function in metabolic reprogramming and senescence.

Main Methods:

• Generation of mice deficient in Lon protease (LONP1).
• In vitro knockdown and overexpression studies of LONP1.
• Analysis of tumor formation, metastasis, cellular proliferation, and senescence.
• Assessment of mitochondrial oxidative phosphorylation (OXPHOS) complexes.

Main Results:

• Homozygous Lonp1 deletion resulted in embryonic lethality.
• Lonp1 haploinsufficiency conferred protection against colorectal and skin tumors.
• LONP1 knockdown inhibited proliferation and tumor/metastasis formation.
• LONP1 overexpression increased tumorigenesis.
• High LONP1 levels correlate with poor prognosis in human colorectal cancer and melanoma.
• LONP1 influences metabolic reprogramming, OXPHOS, and senescence.

Conclusions:

• Lon protease (LONP1) is critical for cellular and organismal viability.
• LONP1 is a central regulator of mitochondrial activity in cancer.
• Targeting LONP1 may offer a therapeutic strategy for cancer treatment.